A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Study Number: 

PH 278315

Phase: 
2
Trial categories: 
Pediatric Cancers
Leukemia
Immunotherapy
Immunomodulatory
Principal Investigator: